Three
Months Ended
|
Three Months
Ended
|
|||||||
June
30, 2009
|
June
30, 2008
|
|||||||
GAAP
Net loss
|
$ | (1,346,950 | ) | $ | (997,130 | ) | ||
Adjustments:
|
||||||||
Expense
- non-cash employee compensation
|
1,246,128 | 1,423,376 | ||||||
Expense
- depreciation
|
7,036 | 3,010 | ||||||
Adjusted
Net Income (Loss)
|
$ | (93,786 | ) | 429,256 |
June
30,
|
December
31,
|
|||||||
2009
|
2008
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$ | 4,910,717 | $ | 5,580,244 | ||||
Restricted
cash
|
650,000 | 650,000 | ||||||
Accounts
receivable - project revenue and reimbursable project
costs
|
3,898,475 | 5,357,804 | ||||||
Prepaid
expenses & other current assets
|
667,407 | 394,315 | ||||||
Total
Current Assets
|
10,126,599 | 11,982,363 | ||||||
Property,
Plant and Equipment -net
|
107,120 | 108,121 | ||||||
Other
Assets
|
||||||||
Patent
costs - net
|
236,215 | 217,875 | ||||||
Security
deposits
|
125,548 | 138,418 | ||||||
Total
Other Assets
|
361,763 | 356,293 | ||||||
Total
Assets
|
$ | 10,595,482 | $ | 12,446,777 | ||||
LIABILITIES
AND STOCKHOLDERS EQUITY
|
||||||||
Current
Liabilities
|
||||||||
Accounts
payable and accrued liabilities
|
$ | 3,637,997 | $ | 5,138,979 | ||||
Total
Liabilities
|
3,637,997 | 5,138,979 | ||||||
Commitments
and contingencies
|
- | - | ||||||
Stockholders'
Equity
|
||||||||
Preferred
stock, $0.001 par value, 50,000,000 authorized shares, no shares issued
and outstanding
|
- | - | ||||||
Common
stock, $0.001 par value, 500,000,000 authorized, 301,841,722 shares issued
and outstanding at June 30, 2009 and 301,493,084 issued and outstanding at
December 31, 2008
|
301,842 | 301,493 | ||||||
Additional
paid in capital - stock and stock equivalents
|
51,086,020 | 48,607,451 | ||||||
Accumulated
Deficit
|
(44,359,385 | ) | (41,489,974 | ) | ||||
Common
stock reserved for issuance, 505,972 shares and 484,055 shares at June 30,
2009 and December 31, 2008, respectively
|
109,297 | 114,787 | ||||||
Deferred
stock compensation
|
(180,289 | ) | (225,959 | ) | ||||
Total
Stockholders' Equity
|
6,957,485 | 7,307,798 | ||||||
Total
Liabilities and Stockholders' Equity
|
$ | 10,595,482 | $ | 12,446,777 |
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||
June
30,
|
June
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Revenue:
|
||||||||||||||||
Consulting
Revenue
|
$ | 3,430,485 | $ | 4,301,500 | $ | 6,374,538 | $ | 8,116,625 | ||||||||
Cost
of Consulting Services Provided
|
1,888,846 | 1,736,562 | 3,637,364 | 3,384,566 | ||||||||||||
Gross
Margin
|
1,541,639 | 2,564,938 | 2,737,174 | 4,732,059 | ||||||||||||
Operating
Expenses
|
||||||||||||||||
General
and administrative
|
1,140,223 | 1,597,941 | 2,107,717 | 3,116,987 | ||||||||||||
Research
and development expenses
|
559,112 | 154,788 | 1,012,917 | 285,449 | ||||||||||||
Stock-based
compensation
|
1,202,357 | 1,423,376 | 2,497,544 | 2,787,179 | ||||||||||||
Total
Operating Expenses
|
2,901,692 | 3,176,105 | 5,618,178 | 6,189,615 | ||||||||||||
Operating
loss
|
(1,360,053 | ) | (611,167 | ) | (2,881,004 | ) | (1,457,556 | ) | ||||||||
Other
Income and (Expenses)
|
||||||||||||||||
Interest
income
|
13,492 | 53,898 | 16,520 | 143,180 | ||||||||||||
Realized
loss on marketable securities and other
|
(389 | ) | (438,750 | ) | (4,927 | ) | (438,750 | ) | ||||||||
Total
Other Income and Expenses
|
13,103 | (384,852 | ) | 11,593 | (295,570 | ) | ||||||||||
Net
loss before income taxes
|
(1,346,950 | ) | (996,019 | ) | (2,869,411 | ) | (1,753,126 | ) | ||||||||
Income
taxes
|
— | 1,111 | — | 31,939 | ||||||||||||
Net
loss
|
(1,346,950 | ) | (997,130 | ) | (2,869,411 | ) | (1,785,065 | ) | ||||||||
Other
Comprehensive Income (Loss)
|
||||||||||||||||
Unrealized
loss on marketable securities
|
— | 128,208 | — | (3,515 | ) | |||||||||||
Total
Comprehensive Loss
|
$ | (1,346,950 | ) | $ | (868,922 | ) | $ | (2,869,411 | ) | $ | (1,788,580 | ) | ||||
Net
Loss Per Common Share, Basic and diluted
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
Weighted
Average Number of shares outstanding for the period (used to compute per
share data)
|
301,841,722 | 299,366,947 | 301,754,563 | 299,215,481 |
Six
months ended
|
||||||||
June
30,
|
||||||||
2009
|
2008
|
|||||||
Operating
Activities:
|
||||||||
Net
Loss
|
$ | (2,869,411 | ) | $ | (1,785,065 | ) | ||
Adjustments
to reconcile net loss from operations to net cash used in operating
activities:
|
||||||||
Stock
based compensation
|
2,519,098 | 2,787,178 | ||||||
Depreciation
and amortization
|
13,040 | 3,467 | ||||||
Changes
in non-cash operating working capital items:
|
||||||||
Accounts
receivable - fees and reimburseable project costs
|
1,459,329 | — | ||||||
Prepaid
expenses and other current assets
|
(260,222 | ) | (150,514 | ) | ||||
Accounts
payable, accrued liabilities and other current liabilities
|
(1,500,982 | ) | (520,359 | ) | ||||
Deferred
revenue
|
— | (3,793,125 | ) | |||||
Deferred
project costs – net
|
— | 371,631 | ||||||
Net
Cash Used In Operating Activities
|
(639,148 | ) | (3,086,787 | ) | ||||
Investing
Activities:
|
||||||||
Property
and equipment
|
(12,039 | ) | — | |||||
Patent
costs
|
(18,340 | ) | — | |||||
Net
Cash Used In Investing Activities
|
(30,379 | ) | — | |||||
Financing
Activities:
|
||||||||
Proceeds
from issuance of common shares
|
— | 49,975 | ||||||
Payments
on notes payable and other
|
— | (10,433 | ) | |||||
Net
Cash Provided by Financing Activities
|
— | 39,542 | ||||||
Net
Decrease In Cash and Cash Equivalents
|
(669,527 | ) | (3,047,245 | ) | ||||
Cash
and Cash Equivalents, Beginning of Period
|
5,580,244 | 9,907,691 | ||||||
Reclassification
of cash equivalents to marketable securities - available for
sale
|
— | (1,674,849 | ) | |||||
Cash
and Cash Equivalents, End of Period
|
$ | 4,910,717 | $ | 5,185,597 | ||||
Supplemental
Disclosure of Cash Flow Information
|
||||||||
Cash
paid during the period for:
|
||||||||
Interest
paid
|
$ | — | $ | 183 | ||||
Income
taxes paid
|
$ | 266,000 | $ | 31,939 |